Executive Team Expansion Quantum-Si has recently onboarded key executives like Chief Commercial Officer Todd Bennett and Chief Product Officer John Vieceli, indicating a potential emphasis on sales strategy and market growth. Leveraging these new leaders' expertise can open doors to valuable partnerships and customer acquisition opportunities.
Recognition for Innovation Being recognized with the Fast Company's Innovation by Design Award showcases Quantum-Si's commitment to breakthrough technologies. This accolade can serve as a powerful sales tool, enhancing brand reputation and credibility, leading to increased interest from potential clients and investors.
Product Enhancements and Expansion The launch of platform enhancements for Platinum and continual expansions in proteome coverage demonstrate Quantum-Si's dedication to advancing its offerings. Sales teams can leverage these improvements to showcase product superiority and appeal to customers seeking cutting-edge solutions in biotechnology research.
Strategic Board Appointments With seasoned professionals like Paula Dowdy and Amir Jafri joining its Board of Directors, Quantum-Si strengthens its strategic vision and industry expertise. Leveraging the network and insights of these board members can create valuable sales opportunities by tapping into their connections and knowledge base.
Industry Accolades and Growth Potential Quantum-Si's revenue range of $10M - 50M positions it among notable players in the biotechnology sector. Its thriving financial health, along with industry comparisons to well-known companies like 23andMe and 10x Genomics, highlights its growth potential and attractiveness to potential investors, signaling lucrative sales possibilities.
867
$100M$1B
201$50M$100M
29
11$10M
151$10M
2.2K$100M$1B
506$10M$50M
1.4K$100M$1B
601$100M$1B
27$10M
45$10MQuantum-Si uses 8 technology products and services including Akamai, Selenium, Next.js, and more. Explore Quantum-Si's tech stack below.
| Quantum-Si Email Formats | Percentage |
| FLast@quantum-si.com | 90% |
| Last@quantum-si.com | 8% |
| First.Last@quantum-si.com | 1% |
| FirstLast@quantum-si.com | 1% |
Biotechnology ResearchConnecticut, United States201-500 Employees
Quantum-Si is The Protein Sequencing Company™ We’re on a mission to put the groundbreaking power of protein sequencing in the hands of every scientist – every lab, everywhere. Follow us and join our exciting journey to empower deeper biologic discovery, enhancing human health. Check out current job listings here: https://www.quantum-si.com/careers/ Nasdaq: $QSI
Company Overview
Funding & FinancialsQuantum-Si has raised a total of $425M of funding over 2 rounds. Their latest funding round was raised on Jun 11, 2021 in the amount of $425M.
Quantum-Si's revenue is in the range of $10M$50M
Funding & FinancialsQuantum-Si has raised a total of $425M of funding over 2 rounds. Their latest funding round was raised on Jun 11, 2021 in the amount of $425M.
Quantum-Si's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com